Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical substanceL04AL03Nipocalimab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 2 registrations
Brazil
Anvisa · 1 registration
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
Croatia
At a glance
- ATC code
- L04AL03
- Registers
- 7
- Registrations
- 8
- With their own page
- 8
- Companies
- 4
All medicines with Nipocalimab
Human medicines from every register that match Nipocalimab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
8 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Imaavy | United States | 1200MG/6.5ML, 300MG/1.62ML | injectable | Marketed | Janssen Biotech |
| Imaavy | European Union | Authorised | Janssen Cilag International NV | ||
| Imaavy 185 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 185 mg/ml | concentrado para solución para perfusión | Authorised | Janssen-Cilag International N.V |
| Imaavy 185 mg/ml concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Janssen-Cilag International NV | |
| Imaavy | Canada | 1200 MG / 6.5 ML | Solution | Marketed | Janssen INC |
| Imaavy | Canada | 300 MG / 1.62 ML | Solution | Marketed | Janssen INC |
| Imaavy | Brazil | Authorised | Janssen-Cilag Farmacêutica Ltda | ||
| Imaavy | Croatia | Authorised |



